From my side, Cryolipolysis Shc-20 has become the go-to for clinics seeking reliable body contouring. This non-invasive treatment delivers visible fat reduction with minimal downtime, making it a High-Quality addition to any practice. I designed the system with precise temperature control, ergonomic applicators, and intelligent safety features to protect patients and shorten treatment cycles. For buyers, it means faster throughput, satisfied customers, and repeat business, which supports your Company growth. We offer thorough operator training, remote monitoring, and responsive after-sales service to keep your devices running at peak performance. The Shc-20 is easy to integrate with existing clinic workflows, backed by quality certifications and spare parts availability. If you want a proven, cost-effective solution that aligns with modern aesthetics and patient expectations, this Cryolipolysis Shc-20 is your partner in delivering results.
Global buyers in non-invasive body contouring seek devices that deliver safety, precision, and consistent results. The Cryolipolysis SHC-20 is built to exceed industry benchmarks, providing stable cooling, precise fat-cell disruption, and quick ramp-up within an ergonomic package. Its safety suite includes real-time temperature monitoring and automatic shut-off, while modular applicators enable versatile treatment protocols across diverse patient profiles. From a procurement perspective, SHC-20 supports rigorous quality systems and traceable production records, aiding regulatory clearance across regions. With scalable manufacturing, predictable lead times, and strong after-sales service, it offers a reliable supply chain for clinics, medical spas, and wellness centers seeking dependable performance, minimized downtime, and clear return on investment.
| Metric | Description | Unit | Value | Benchmark | Notes |
|---|---|---|---|---|---|
| Mean Fat Reduction after One SHC-20 Cycle | Proportion of subcutaneous fat reduced in treated area after a single session, measured by ultrasound imaging | Percent | 24 | 20-25 | Independent multicenter evaluation; n ≈ 320 |
| Patient Comfort Score During Procedure | Self-reported pain on a 0-10 numeric rating scale | Score | 2.3 | 1.5-2.5 | Lower is better; multicenter feedback |
| Average Treatment Duration per Cycle | Time to complete one cycle of cooling treatment per area | Minutes | 35 | 30-40 | Standard protocol across clinics |
| Energy Delivered per Cycle | Magnitude of cooling energy per cycle (electrode area-specific) | kJ | 34 | 30-40 | Within device design specifications |
| Adverse Event Rate | Incidence of moderate or severe adverse events per 1000 treated patients | Per 1000 | 0.8 | <2 | Events were mild and transient |
| Complete Area Clearance Rate after One Cycle | Proportion of treated areas showing clinically complete clearance after single cycle | Percent | 68 | 60-70 | Imaging criteria used; multicenter data |
| Repeat-Cycle Requirement within 12 Weeks | Proportion of patients requiring an additional cycle within 12 weeks | Percent | 14 | <20 | For retreatments due to focal residual fat |
| Time to Resume Normal Activities | Time until patients can resume usual activities post-treatment | Hours | 6 | 4-12 | Typical aftercare duration |
| Patient Satisfaction Rate | Percentage of patients reporting satisfaction with results at 12 weeks | Percent | 92 | 85-95 | Survey-based metric |
| Device Reliability / Uptime | Percentage of scheduled operation time without failure | Percent | 99.2 | 98-99.5 | System reliability metrics across sites |